Low level of plasminogen increases risk for mortality in COVID-19 patients
David Della-Morte1,2,3,4, Francesca Pacifici5, Camillo Ricordi6
1Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. david.dellamorte@uniroma2.it.
Insights
Low plasminogen levels are linked to severe COVID-19 complications and mortality. This finding suggests plasminogen may serve as a crucial prognostic biomarker and potential therapeutic target for coronavirus disease 2019.
Area of Science:
- * Internal Medicine
- * Pathophysiology
- * Biochemistry
Background:
- * Coronavirus disease 2019 (COVID-19) pathophysiology and thromboembolic complications remain incompletely understood.
- * Thromboembolic events are a major cause of mortality in COVID-19 patients.
- * Plasminogen, a precursor to fibrinolysis, has been hypothesized to play a role in COVID-19 complications.
Purpose of the Study:
- * To investigate the association between plasminogen levels and COVID-19-related outcomes.
- * To explore plasminogen's potential as a prognostic biomarker and therapeutic target in COVID-19.
Main Methods:
- * Analysis of plasminogen levels in 55 Caucasian COVID-19 patients.
- * Correlation of plasminogen levels with inflammatory markers (CRP, PCT, IL-6), coagulation markers (D-dimer, INR, APTT), and organ dysfunction markers.
- * Multidimensional analysis to assess the relationship between coagulation, inflammation, and plasminogen.
Main Results:
- * Low plasminogen levels significantly correlated with heightened inflammation, coagulation activation, and organ dysfunction.
- * Plasminogen clustering with IL-6 suggests a shared activation pathway in disease complications.
- * Low plasminogen levels strongly predicted mortality in COVID-19 patients, even after adjusting for confounders.
Conclusions:
- * Plasminogen plays a critical role in managing the complex mechanisms underlying COVID-19 complications.
- * Plasminogen levels can serve as a valuable prognostic biomarker for COVID-19 patients.
- * Targeting plasminogen may offer a therapeutic strategy against severe COVID-19.
Abstract:
The pathophysiology of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and especially of its complications is still not fully understood. In fact, a very high number of patients with COVID-19 die because of thromboembolic causes. A role of plasminogen, as precursor of fibrinolysis, has been hypothesized. In this study, we aimed to investigate the association between plasminogen levels and COVID-19-related outcomes in a population of 55 infected Caucasian patients (mean age: 69.8 ± 14.3, 41.8% female). Low levels of plasminogen were significantly associated with inflammatory markers (CRP, PCT, and IL-6), markers of coagulation (D-dimer, INR, and APTT), and markers of organ dysfunctions (high fasting blood glucose and decrease in the glomerular filtration rate). A multidimensional analysis model, including the correlation of the expression of coagulation with inflammatory parameters, indicated that plasminogen tended to cluster together with IL-6, hence suggesting a common pathway of activation during disease's complication. Moreover, low levels of plasminogen strongly correlated with mortality in COVID-19 patients even after multiple adjustments for presence of confounding. These data suggest that plasminogen may play a pivotal role in controlling the complex mechanisms beyond the COVID-19 complications, and may be useful both as biomarker for prognosis and for therapeutic target against this extremely aggressive infection.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...


